EP.08.33 A Real-World Study of Resectable NSCLC Following Neoadjuvant Immunotherapy: Should Postoperative Adjuvant Immunotherapy Be Recommended?
Back to course
Asset Subtitle
Ming Li
Meta Tag
Speaker Ming Li
Topic Local-Regional Non-small Cell Lung Cancer
Powered By